Bullous Pemphigoid as Pruritus in the Elderly A Common Presentation

被引:49
作者
Bakker, Christiaan V. [1 ]
Terra, Jorrit B. [1 ]
Pas, Hendri H. [1 ]
Jonkman, Marcel F. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Ctr Skin Blistering Dis, Groningen, Netherlands
关键词
LOW-DOSE METHOTREXATE; GENERALIZED PRURITUS; TOPICAL STEROIDS; SUBACUTE PRURIGO; NODULARIS; PRODROME; DISEASES; VARIANT; AUTOANTIBODIES; DERMATOSES;
D O I
10.1001/jamadermatol.2013.756
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
IMPORTANCE In the literature, patients with bullous pemphigoid have been reported to have itch without blisters. Clinical observations in these patients have varied from eczematous or urticarial to papular or nodular skin lesions. Here we investigated the spectrum of clinical variants. OBSERVATIONS Fifteen patients with itch without blisters had immunopathologic findings of bullous pemphigoid. Mean age at diagnosis was 81.7 years. No blistering occurred during the mean 2.2 years of follow-up. Mean delay of diagnosis was 2.8 years. Clinical symptoms were heterogeneous: pruritus sine materia (no primary skin lesions), eczematous, urticarial, papular, and/or nodular skin lesions were seen. Treatment with potent topical corticosteroids or methotrexate sodium led to remission in 11 patients. CONCLUSIONS AND RELEVANCE Itch without skin lesions can be the only symptom of bullous pemphigoid. Therefore, it is important to include serologic and direct immunofluorescence in the diagnostic algorithm of itch. We propose the unifying term pruritic nonbullous pemphigoid for all patients with immunopathologic findings of bullous pemphigoid, itch, and no blisters.
引用
收藏
页码:950 / 953
页数:4
相关论文
共 32 条
[1]
Alonso-Llamazares J, 1998, INT J DERMATOL, V37, P508
[2]
THE PRODROME OF BULLOUS PEMPHIGOID [J].
AMATO, DA ;
SILVERSTEIN, J ;
ZITELLI, J .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1988, 27 (08) :560-563
[3]
DETERMINATION OF THE OPTIMUM SITE FOR DIAGNOSTIC-BIOPSY FOR DIRECT IMMUNOFLUORESCENCE IN BULLOUS PEMPHIGOID [J].
ANSTEY, A ;
VENNING, V ;
WOJNAROWSKA, F ;
BHOGAL, B ;
BLACK, MM .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1990, 15 (06) :438-441
[4]
ASBRINK E, 1981, ACTA DERM-VENEREOL, V61, P417
[5]
[6]
Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: Aan open prospective study of 18 cases [J].
Dereure, O ;
Bessis, D .
ARCHIVES OF DERMATOLOGY, 2002, 138 (09) :1255-1256
[7]
Di Zenzo Giovanni, 2007, Adv Dermatol, V23, P257, DOI 10.1016/j.yadr.2007.07.013
[8]
Bullous pemphigoid: From the clinic to the bench [J].
Di Zenzo, Giovanni ;
della Torre, Rocco ;
Zambruno, Giovanna ;
Borradori, Luca .
CLINICS IN DERMATOLOGY, 2012, 30 (01) :3-16
[9]
Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid [J].
Dimson, OG ;
Giudice, GJ ;
Fu, CL ;
Van den Bergh, F ;
Warren, SJ ;
Janson, MM ;
Fairley, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (05) :784-788
[10]
Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study [J].
Du-Thanh, A. ;
Merlet, S. ;
Maillard, H. ;
Bernard, P. ;
Joly, P. ;
Esteve, E. ;
Richard, M. A. ;
Pauwels, C. ;
Ingen-Housz-Oro, S. ;
Guillot, B. ;
Dereure, O. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) :1337-1343